Drug
Lercanidipine clinical trials
- studies test it
- 9
- open now
- 1
- in phase 3
- 1
- first study started
- 2004
Keep track of what changes. Save the lercanidipine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 1
- Phase 4
- 3
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
Lee's Pharmaceutical Limited (2) · LG Life Sciences (2) · Aarhus University Hospital (1) · RECORDATI GROUP (1) · UCB Pharma (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · University of Aarhus (1)
Often tested with
Tested in the same studies.
Valsartan (2) · Hydrochlorothiazide (2) · Clopidogrel (1) · Amlodipine (1) · Ramipril (1) · Losartan (1) · Enalapril (1) · Spironolactone (1)
Studies
Open first, then newest update. How each study uses lercanidipine is read from its arms, and is right about nine times in ten.
Testing it · 9
- The Role of Skin Sodium Accumulation in Chronic Kidney DiseaseRecruitingNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT07020104Written as Lercanidipine
- Zainidip in Renal Artery StenosisCompletedPhase 4Lee's Pharmaceutical LimitedNCT02594410Written as Lercanidipine
- Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for HypertensionCompletedPhase 4Lee's Pharmaceutical LimitedNCT01520285Written as Zanidip
- Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive PatientsCompletedPhase 3LG Life SciencesNCT01928628Written as Lercanidipine 10mg
- Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedPhase 4Aarhus University HospitalNCT01180413Written as Lercanidipine
- Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential HypertensionCompletedPhase 2RECORDATI GROUPNCT01093807Written as Lercanidipine
- Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential HypertensionCompletedPhase 2LG Life SciencesNCT01122251Written as Lercanidipine + Valsartan
- Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisTerminatedNot applicableUniversity of AarhusNCT00424801Written as Lercanidipine
- Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese PatientsCompletedNot applicableUCB PharmaNCT00160498Written as Lercanidipine
As the comparator · 1 — what is tested is compared with lercanidipine
Codes
What other systems call lercanidipine · ClinicalTrials.gg INT003449
- MeSH (NLM) C060343lercanidipineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) V7XTJ4R0BHLERCANIDIPINEConfirmed FDA, NLM, Wikidata
- RxNorm 135056Confirmed FDA, Wikidata
- Wikidata Q410492lercanidipineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81687LercanidipineOne source FDA
- DrugBank DB00528One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C060343 | lercanidipine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | V7XTJ4R0BH | LERCANIDIPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 135056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410492 | lercanidipine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81687 | Lercanidipine | One source FDA |
| DrugBank | DB00528 | — | One source Wikidata |
Also registered as lercanidipine hydrochloride (UNII OA8TFX68PE · RxNorm 153679).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.